Cargando…
Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study
OBJECTIVE: To determine whether the use of glucagon-like peptide 1 (GLP-1) receptor agonists, dipeptidyl peptidase 4 (DPP-4) inhibitors, and sodium-glucose co-transporter-2 (SGLT-2) inhibitors, separately, is associated with a decreased risk of exacerbations of chronic obstructive pulmonary disease...
Autores principales: | Pradhan, Richeek, Lu, Sally, Yin, Hui, Yu, Oriana H Y, Ernst, Pierre, Suissa, Samy, Azoulay, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623550/ https://www.ncbi.nlm.nih.gov/pubmed/36318979 http://dx.doi.org/10.1136/bmj-2022-071380 |
Ejemplares similares
-
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
por: Suissa, Samy, et al.
Publicado: (2012) -
Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study
por: Pradhan, Richeek, et al.
Publicado: (2023) -
Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
por: Douros, Antonios, et al.
Publicado: (2018) -
Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study
por: Faillie, Jean-Luc, et al.
Publicado: (2014) -
Metformin and the Risk of Cancer: Time-related biases in observational studies
por: Suissa, Samy, et al.
Publicado: (2012)